BC
QNRX

Birchview Capital’s Quoin Pharmaceuticals QNRX Stock Holding History

Birchview Capital’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$132K Buy
+20,000
New +$181K 0.08% 69

Other funds holding QNRX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Birchview Capital's QNRX Position: Q1 2026 in Review

Birchview Capital opened a new position in Quoin Pharmaceuticals (QNRX) in Q1 2026: 20,000 shares worth $132K. The stake represents 0.08% of the portfolio and ranks #69 among its holdings.

22 funds tracked by Wall St. Rank hold QNRX as of Q1 2026.

  • Birchview Capital held 20,000 shares of Quoin Pharmaceuticals worth $132K as of Q1 2026.
  • Quoin Pharmaceuticals was a new Birchview Capital position in Q1 2026.
  • Quoin Pharmaceuticals made up 0.08% of Birchview Capital's portfolio in Q1 2026, its #69 holding.
  • 22 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2026.

Based on Birchview Capital's 13F filing for Q1 2026, filed 15 May 2026.